Author:
Wang Jishi,Ma Dan,Li Yan,Yang Yuan,Hu Xiaoyan,Zhang Wei,Fang Qin
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference21 articles.
1. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.;Brown;Cancer Res,1998
2. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450P450-reductase-based cancer gene therapy.;Jounaidi;Cancer Res,2000
3. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.;Krishna;Cancer Res,1997
4. The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothcin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis.;Hasinoff;Anticancer Drugs,1999
5. Secreted human -glucuronidase: a novel tool for gene-directed enzyme prodrug therapy.;Weyel;Gene Ther,2000
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献